164 related articles for article (PubMed ID: 33469164)
1. Continuous infusion of vancomycin improved therapeutic levels in term and preterm infants.
Round A; Clifton E; Stachow L; Mittal S; Yadav K; Ashraf H; Sanghera RS; Ng KF
J Perinatol; 2021 Jun; 41(6):1459-1466. PubMed ID: 33469164
[TBL] [Abstract][Full Text] [Related]
2. Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial.
Gwee A; Cranswick N; McMullan B; Perkins E; Bolisetty S; Gardiner K; Daley A; Ward M; Chiletti R; Donath S; Hunt R; Curtis N
Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30700564
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of intermittent and continuous infusion vancomycin for methicillin-resistant Staphylococcus aureus bacteremia.
Gilliam D; Acosta D; Carvour ML; Walraven C
Eur J Clin Pharmacol; 2024 Jan; 80(1):75-81. PubMed ID: 37897529
[TBL] [Abstract][Full Text] [Related]
4. When There Is No Trough: Use and Outcomes of Continuous-Infusion Vancomycin at a Free-Standing Children's Hospital.
Wysocki E; Tansmore J
J Pediatr Pharmacol Ther; 2022; 27(5):452-456. PubMed ID: 35845557
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
Gwee A; Cranswick N; Donath SM; Hunt R; Curtis N
BMJ Open; 2018 Nov; 8(11):e022603. PubMed ID: 30391914
[TBL] [Abstract][Full Text] [Related]
6. Retrospective multicentre matched cohort study comparing safety and efficacy outcomes of intermittent-infusion versus continuous-infusion vancomycin.
Ma NH; Walker SAN; Elligsen M; Kiss A; Palmay L; Ho G; Powis J; Bansal V; Leis JA
J Antimicrob Chemother; 2020 Apr; 75(4):1038-1046. PubMed ID: 31919504
[TBL] [Abstract][Full Text] [Related]
7. Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis.
Hao JJ; Chen H; Zhou JX
Int J Antimicrob Agents; 2016 Jan; 47(1):28-35. PubMed ID: 26655032
[TBL] [Abstract][Full Text] [Related]
8. Intermittent vs. continuous vancomycin infusion for gram-positive infections: A systematic review and meta-analysis.
Chu Y; Luo Y; Quan X; Jiang M; Zhou B
J Infect Public Health; 2020 Apr; 13(4):591-597. PubMed ID: 31530441
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline.
McKamy S; Chen T; Lee M; Ambrose PJ
Am J Health Syst Pharm; 2012 Dec; 69(23):2066-71. PubMed ID: 23172265
[TBL] [Abstract][Full Text] [Related]
10. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies.
Wang B; Xu L; Li Q; Man S; Jin C; Liu L; Zhan S; Ning Y
BMC Cancer; 2020 Oct; 20(1):1021. PubMed ID: 33087103
[TBL] [Abstract][Full Text] [Related]
11. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.
Wysocki M; Delatour F; Faurisson F; Rauss A; Pean Y; Misset B; Thomas F; Timsit JF; Similowski T; Mentec H; Mier L; Dreyfuss D
Antimicrob Agents Chemother; 2001 Sep; 45(9):2460-7. PubMed ID: 11502515
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review.
Alonso-Moreno M; Mejías-Trueba M; Herrera-Hidalgo L; Goycochea-Valdivia WA; Gil-Navarro MV
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438962
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Continuous Infusion Vancomycin in a Pediatric Hematology/Oncology Population.
King MA; Cross SJ; Morton TH; Hijano DR; Greene WL; Sun Y; Tang L; Pauley JL; Bourque MS; Christensen AM
Pediatr Infect Dis J; 2024 Jun; 43(6):520-524. PubMed ID: 38359358
[TBL] [Abstract][Full Text] [Related]
14. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
[TBL] [Abstract][Full Text] [Related]
15. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.
Demirel B; İmamoglu E; Gursoy T; Demirel U; Topçuoglu S; Karatekin G; Ovali F
J Neonatal Perinatal Med; 2015; 8(2):149-55. PubMed ID: 26410440
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Sin JH; Newman K; Elshaboury RH; Yeh DD; de Moya MA; Lin H
J Antimicrob Chemother; 2018 Jan; 73(1):199-203. PubMed ID: 29040561
[TBL] [Abstract][Full Text] [Related]
18. Neonatal vancomycin continuous infusion: still a confusion?
Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
[TBL] [Abstract][Full Text] [Related]
19. Experience with Continuous Infusion Vancomycin Dosing in a Large Pediatric Hospital.
Hurst AL; Baumgartner C; MacBrayne CE; Child J
J Pediatric Infect Dis Soc; 2019 May; 8(2):174-179. PubMed ID: 29718415
[TBL] [Abstract][Full Text] [Related]
20. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
